UNSPSC 85516218: Insertion of infusion device into left femoral artery, percutaneous endoscopic approach

This classification denotes the group of activities that yields a surgical intervention or procedure to insertion of infusion device into left femoral artery, percutaneous endoscopic approach. This surgical intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 04HL43Z

UNSPSC 85516218, Insertion of infusion device into left femoral artery, percutaneous endoscopic approach, is a Commodity code that shows little relevant recent activity in state and local procurement. The recent opportunities tagged under this code are medical evaluation services, pharmacy benefit management, occupational medical surveillance, temporary health professional staffing, surgical procedure carve-out benefits, and emergency medical services for youth in detention—none of which involve insertion of infusion devices into femoral arteries or other clinical interventional procedures. The code's narrow procedural scope and the mismatch between its clinical specification and the broader health services and benefits administration work actually being solicited suggest this code may be misapplied in state and local tagging systems or sees minimal direct procurement activity among state and local health agencies.

The issuing bodies posting under this tag span county systems (Harris County Juvenile Probation Department, Collier County, Santa Clara County Health System), cities (Phoenix Retirement Office, Long Beach), and state transportation agencies (Washington State Department of Transportation). Recent solicitations include the City of Phoenix Retirement Office's RFP for independent medical evaluation services (RTMRFP26001, due October 16, 2026), the City of Long Beach's RFP for a surgical procedure carve-out benefit program (HR26753, due October 7, 2026), and the Washington State Department of Transportation's RFP for occupational medical surveillance (RFP20260825, due October 9, 2026). Geographic activity spans Arizona, California, Washington, Florida, and Texas. No state and local procurement activity directly supporting insertion of femoral infusion devices is evident in the recent opportunities block.